Introduction
Esophageal cancer represents the sixth leading cause of cancer deaths and the eighth most common type of cancer worldwide (1, 2) . Despite the use of multimodal treatments such as radical surgery, chemotherapy and radiotherapy, the 5 year overall survival rate of patients with esophageal squamous cell carcinoma (ESCC) remains <14% (2) (3) (4) . A poor survival rate in ESCC patients is highly associated with a frequent local invasion and distant metastasis, and >50% of patients have either unresectable cancer or radiographically visible metastases at diagnosis (2, 5) . The absence of the serosa and the presence of the extensive lymphatics in the esophagus are probably some of the contributing factors to the high frequency of local invasion and metastasis in ESCC (5) . However, our understanding of the molecular mechanisms that regulate local invasiveness and metastatic potential of ESCC remain incomplete. To improve the overall outcome for patients with ESCC, it is important to understand the molecular mechanisms underlying these processes, thereby useful biomarkers and novel therapeutic targets can be discovered.
Over the past few years, microRNAs (miRNAs) have been recognized as critical regulators of cancer invasion and metastasis, either as promoters or as suppressors (6) (7) (8) . Deregulation of miRNAs in cancer may result in aberrant expression of proteins that regulate cancer cell invasiveness, such as cytoskeletal regulatory proteins, cell adhesion molecules or proteins regulating epithelial-to-mesenchymal transition (9) . Recently, the miR-200 family was identified as potent suppressors of epithelial-to-mesenchymal transition by directly targeting the E-cadherin transcriptional repressors, ZEB1 and ZEB2, thereby suppressing tumor invasion and/or metastasis (10) (11) (12) (13) (14) . The miR-200 family is comprised of five members that are encoded within two clusters: the miR-200b-200a-429 cluster (miR-200b cluster) located on chr1p36 and the miR-200c-141 cluster located on chr12p13. Our previous investigation using miRNA profiling has revealed that the miR-200b cluster members are consistently downregulated in ESCC (15) . Recently, a study showed that a high level of miR-200c correlated with chemoresistance and a short survival in ESCC patients (16) . However, our knowledge about the exact roles played by the miR-200 family in ESCC and the underlying molecular mechanisms remain relatively unclear.
In this study, we firstly confirmed that the miR-200b cluster members are frequently downregulated in ESCC, and this abnormality significantly correlates with a poor prognosis and unfavorable clinicopathological features in ESCC patients. Our in vitro studies suggest that miR-200b strongly represses the invasiveness and modulates the cytoskeletal and adhesive machinery in ESCC cells. Lastly, mass spectrometry (MS) studies allowed us to discover Kindlin-2 as an important mediator of the tumor suppressor functions of miR-200b.
Materials and methods

Clinical samples
Human ESCC samples and adjacent non-tumorous esophageal epithelial tissues were collected between October 2007 and December 2008 directly after surgical resection at the Department of Tumor Surgery of Shantou Central Hospital, China. The cases were selected based on a clear pathological diagnosis, follow-up data, and had not received previous local or systemic treatment. The histological characterization and clinicopathological staging of the samples were performed in accordance with the seventh edition of American Joint Committee on Cancer Tumor-Nodes-Metastasis staging system. Detailed clinical information of the ESCC patients is described in Supplementary Table 1, available at Carcinogenesis Online. The study was approved by the ethical committee of the Central Hospital of Shantou City and the ethical committee of Shantou University Medical College, and written informed consent was obtained from all surgical patients to use resected samples for research.
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and Hepatology, Chinese PLA General Hospital, Beijing, China. EC109 and EC9706 were obtained from Chinese Academy of Medical Sciences, Beijing, China. The ESCC cell lines used in this study were cultured according to the methods described below: KYSE510, KYSE180, KYSE150, KYSE70 and TE3 cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum. EC109 and EC9706 cells were maintained in Dulbecco's modified Eagle's medium plus 10% newborn calf serum.
In vitro invasion and migration assays
Cell invasion, migration assays were performed as described below: 48 h after transfection with 10 nM miR-200b mimic or 200 nM anti-200b or their corresponding negative control RNA, cells were starved for 24 h and 1 × 10 5 starved cells were seeded into transwells (BD Biosciences) with 8 μm pore size membranes coated with or without matrigel (for invasion and migration assays, respectively). After 48 h, cells within the transwells were removed and migrated/invaded cells on the bottom of the transwells were stained with crystal violet. Photos of migrated/invaded cells on the transwell membrane were taken under ×200 magnification, and the numbers of migratory/invaded cells were counted from at least five different fields.
RNA isolation and qRT-PCR
Total RNA was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA). For the quantitative real-time PCR (qRT-PCR) of miR-200a, miR-200b, miR-429 and RNU6B (U6, endogenous control), TaqMan MicroRNA Assay kits (Applied Biosystems) were used and real-time PCR reaction was carried out using ABI 7500 fast real-time PCR system (Applied Biosystems) as described before (15) .
Vector construction and site-directed mutagenesis
The coding region of Kindlin-2 was amplified and cloned (BamHI and XhoI) into the eukaryotic expression vector pcDNA3.1 (Invitrogen) to generate pcDNA3.1-Kindlin-2 expression vector. To construct the luciferase reporter vector, the 3′-untranslated region (3′-UTR) of FERMT2, CDK2, CFL2, HMOX1, PAF, PAK2, RALB and RDX containing the putative miR-200b binding site(s) were amplified and cloned (XbaI and FseI) into pGL3-Control vector (Promega). All the primers used for gene cloning are described in Supplementary Table 2, available at Carcinogenesis Online. For site-directed mutagenesis, Fast Mutagenesis System (TransGen Biotech, Beijing, China) was used, and the experiment was performed according to the manufacturer's instructions. Primers for mutagenesis are listed in Supplementary Table 2 , available at Carcinogenesis Online.
Oligonucleotide transfection
Syn-hsa-miR-200b miScript miRNA Mimic, Anti-hsa-miR-200b miScript miRNA Inhibitor, Kindlin-2 small interfering RNA (siRNA) and their corresponding negative control RNAs were all purchased from Qiagen. The sequence of Kindlin-2 siRNA is 5′-CTGGTGGAGAAACTCGATGTA-3′. Oligonucleotide alone transfection was performed with Hiperfect reagents (Qiagen) and cotransfection of oligonucleotide and vectors were performed with Attractene reagents (Qiagen).
Luciferase reporter assay
The firefly luciferase construct was cotransfected with a control Renilla luciferase vector into EC109 cells in the presence of either miR-200b mimic or anti200b or corresponding negative control RNA. After 48 h, luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega). Data are presented as ratios between firefly and Renilla fluorescence activities. The experiments were performed independently in triplicate.
Western blot and Rho GTPase activation assay
Proteins were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membrane (Millipore). The membranes were blocked with 5% non-fat milk and incubated with antibodies against Kindlin-2 (1:2000; Millipore), pFAK(Tyr397) (1:1000; Invitrogen), FAK (1:500; BD Transduction Laboratories) and β-actin (1:10 000; Sigma). The proteins were detected with Western Blot Luminol Reagent (Santa Cruz).
The pull down of the guanosine triphosphate (GTP)-bound form of Rhofamily GTPases was performed using RhoA and Cdc42/Rac1 activation assay kits (Cytoskeleton) in accordance with the manufacturer's instructions. Protein quantitative analysis was performed by western blot analysis using antibodies against RhoA, Cdc42 and Rac1 provided within the kits.
Immunohistochemistry
Paraffin-embedded tissue blocks were cut into 4 μm sections and processed for immunohistochemistry (IHC) with a protocol described previously (17) . Antibodies against Kindlin-2 (1:500; Millipore) were used. Scoring was classified into four grades: no reactivity scored 0, faint reactivity scored 1, moderate reactivity scored 2 and strong reactivity scored 3. . After culturing for seven passages, the cells were seeded into 6-well plates, the 'light' labeled cells were mock-transfected with 10 nM negative control RNA and the 'heavy' labeled cells were transfected with 10 nM miR-200b mimic. At 48 h posttransfection, the cells were trypsinized and washed with ice-cold phosphate-buffered saline before evaluating cell concentrations. Then, cells were combined at a ratio of 1:1 (1 × 10 6 each) and splitted with Laemmli buffer (Bio-Rad). The lysates were resolved in a 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel and visualized by colloidal Coomassie staining (Invitrogen). Gel bands of interest were excised into 10 sections and subjected to in-gel digestion, respectively. Briefly, the gel bands were sliced into small pieces (~1 mm 3 ) and destained with 25 mM ammonium bicarbonate in ethanol/water (50:50, vol/vol). The destained gel pieces were washed in an acidic buffer (acetic acid/ethanol/water, 10:50:40, vol/vol/vol) three times for 1 h each time, and in water two times for 20 min each time. The gel pieces were dehydrated in acetonitrile (Fisher Scientific) and dried in a SpeedVac (Thermo Fisher). Two hundred nanograms of porcine-modified trypsin (Promega) in 50 mM ammonium bicarbonate was added to the dried gels and incubated overnight at 37°C. Tryptic peptides were sequentially extracted from the gel pieces with 50% acetonitrile (acetonitrile/water/trifluoroacetic acid, 50:45:5, vol/vol/vol) and 75% acetonitrile (acetonitrile/water/trifluoroacetic acid, 75:24:1, vol/vol/vol). The peptide extracts were pooled and dried in a SpeedVac. Every mixture of peptides was desalted using a μ-C18 ZipTip (Millipore), respectively, before high-performance liquid chromatography (HPLC)/MS/MS analysis.
Nano-HPLC/mass spectrometric analysis and protein sequencing alignment. This experiment was performed in a single run. The tryptic digests were injected into a Nano-LC system (Eksigent Technologies) and analyzed by an LTQ-Orbitrap Velos mass spectrometer (Thermo Fisher Scientific). Briefly, each tryptic digest was dissolved in 10 μl of HPLC buffer A [0.1% (vol/vol) formic acid in water], and 2 μl was injected into a Nano-LC system. Peptides were separated on a homemade capillary HPLC column (100 mm length × 75 μm inner diameter) containing Jupiter C12 resin (4 μm particle size, 90 Å pore diameter; Phenomenex) with a 2 h HPLC gradient from 5 to 90% HPLC buffer B (0.1% formic acid in acetonitrile) at a flow rate of 200 nl/min and electrosprayed directly into the mass spectrometer using a nanospray source. The LTQ-orbitrap Velos mass spectrometer was operated in a data-dependent mode with resolution R = 60 000 at m/z 400. Full-scan MS spectra from m/z 300-2000 were acquired in the Orbitrap. The 20 most intense ions were sequentially isolated in the linear ion trap and subjected to collision-activated dissociation with a normalized energy of 35%. The exclusion duration for the data-dependant scan was 36 s, the repeat count was 2 and the exclusion window was set at ±2 Da. Automatic gain control settings were 1E6 for full-scan Orbitrap analysis, 1E4 for MSn scanning ion trap and 6E4 for MSn scan in Orbitrap. Signal threshold for collision-induced dissociation acquisition was set at 5000. The resulting MS/ MS data were searched against the IPI human protein sequence database using Mascot search engine (v2.2) and Maxquant software (v1.0.13.13) with an overall false discovery rate for peptides of <1%. Trypsin was specified as the proteolytic enzyme, and up to four missed cleavage sites per peptide were allowed. Oxidation of methionine and lysine-13 C 6 was fixed as variable modifications. Charge states of +1, +2 or +3 were considered for parent ions. The quantification was performed using Maxquant software (v1.0.13.13) tool.
Statistical analysis
All statistical analyses were performed using the SPSS V.13.0 statistical software package. The Wilcoxon signed-rank test was used to compare the expression levels of miR-200b cluster members between ESCC tissues and their paired nontumorous tissues. To evaluate significant differences between two independent H.-F.Zhang et al.
groups of samples, Student's t-test or Mann-Whitney U-test were used. Survival curves were plotted using the Kaplan-Meier method and compared using the log-rank test, and X-tile software was used for the selection of optimal cutpoints before analysis (18) . The chi-square test or Fisher's exact test was used to analyze the association of miR-200b-200a-429 expression and clinical-pathological parameters, and the same cutpoints were used as in the survival analysis. Differences were considered significant when the P value was <0.05.
Results
Decreased expression of the miR-200b cluster in ESCC correlates with shorter patient survival, lymph node metastasis and advanced clinical stage
Our previous studies using miRNA profiling applied to three cases of ESCC revealed a downregulation of the miR-200b-200a-429 cluster in ESCC, as compared with adjacent benign esophageal tissues (15) . In the present study, we aimed to confirm these findings using qRT-PCR applied to 88 pairs of ESCC and the adjacent benign esophageal tissues. As illustrated in Figure 1A , the three miR-200b cluster members (namely, miR-200b, miR-200a and miR-429) are clustered within a short segment of chromosome 1. Using Wilcoxon signedrank test, we confirmed that the expression levels of the miR-200b cluster members were significantly lower in ESCC when compared with the adjacent benign esophageal tissues ( Figure 1B , P < 0.05). We also found that the expression levels of these three miRNAs significantly correlated with each other in ESCC ( Figure 1C , P < 0.001).
Kaplan-Meier analysis was performed to compare the prognosis of patients carrying tumors with different expression levels of the three miR-200b cluster members. As shown in Figure 1D , ESCC patients carrying tumors expressing low levels of the miR-200b cluster members had a significantly shorter survival, as compared with patients carrying tumors with high expression levels of these miRNAs (P < 0.05). We also revealed that a relatively low expression of miR-200b and miR-429 significantly correlated with lymph node metastasis ( Figure 1E and Supplementary Table 3 , available at Carcinogenesis Online, P = 0.020). Given that miR-200b showed the highest correlation with the clinical outcomes of ESCC patients, we examined miR-200b expression in a panel of ESCC cell lines (n = 7), and the data showed that miR-200b was expressed at a relatively low level, compared with benign esophageal tissues ( Figure 1F) . Figure 2A . The labeling efficiency test data showed that >95% of newly synthesized proteins were labeled with lysine-13 C 6 before miR-200b mimic transfection (Supplementary Figure 1 , available at Carcinogenesis Online). A total of 2174 proteins were identified, and the majority of these 2174 proteins had an heavy/light ratio between 0.9 and 1.1 (Supplementary Table 4 , available at Carcinogenesis Online), which is consistent with the previous report that ectopic expression of miRNAs only causes moderate changes in the overall protein synthesis (19) . Three hundred and nine of these 2174 proteins were considered probable candidates since they had an heavy/light ratio ≤0.9 (Supplementary Table 5 , available at Carcinogenesis Online). Of these 309 downregulated proteins, 57 overlapped with the gene lists generated by the in silico prediction using the 'TargetScan' algorithm that revealed 3414 potential miR-200b targets based on their potential miR-200b binding site(s) on their 3′-UTRs (Figure 2B  and Supplementary Table 5 , available at Carcinogenesis Online). Notably, 4/57 genes have been previously published to be direct targets of miR-200, including MARCKS, CFL2, TUBB3 and MATR3 (7, (20) (21) (22) , and 2/57 were shown to be putative targets that can be downregulated by miR-200, including CRTAP and SERPINH1 (7) .
Identification of miR-200b target genes using quantitative MS
Of the remaining 51 potential targets of miR-200b, we performed validation studies. We identified seven potential targets that have been implicated in tumorigenesis or malignant progression in other cancer types, including CDK2, FERMT2 (encodes Kindlin-2 protein), HMOX1, PAF (KIAA0101), PAK2, RALB and RDX (23) (24) (25) (26) (27) (28) (29) (30) . CFL2, which was shown previously to be a miR-200b target gene (7), served as the positive control in our subsequent validation analysis. Our experimental approach was to clone the 3′-UTRs of these eight candidates into a luciferase reporter vector, as detailed in Materials and methods. By performing bidirectional screening using miR-200b mimic and miR-200b inhibitor, our studies allowed us to validate three novel miR-200b targets, including CDK2, PAF and Kindlin-2 ( Figure 2C ). The luciferase reporters containing the 3′-UTR of the other four putative miR-200b targets were shown not to respond accordingly to the manipulation of miR-200b expression levels, probably due to the fact that their protein expression was regulated by miR-200b through indirect mechanisms other than direct binding of miR-200b to their 3′-UTR.
Kindlin-2 is a novel target of miR-200b in ESCC cells
Among the three newly identified miR-200b targets, Kindlin-2 was shown previously to promote cancer cell migration and invasiveness (23, 24) . Our following observations support the concept that Kindlin-2 is indeed a target of miR-200b in ESCC. First, in silico prediction revealed two potential binding sites of miR-200b on Kindlin-2 3′-UTR, and simultaneous mutation of both potential binding sites abolished the suppression of miR-200b mimic on the luciferase activity ( Figure 2D ). Second, an inverse correlation between the expression of Kindlin-2 and miR-200b can be observed in a panel of six ESCC cell lines ( Figure 1F and Figure 2E) . Third, to test whether miR-200b indeed regulates the protein expression of Kindlin-2, three cell lines (i.e. EC9706, EC109 and KYSE510) that expressed the lowest level of miR-200b and the highest level of Kindlin-2 were chosen to transfect with miR-200b mimic, whereas KYSE150 cells that had the highest expression of miR-200b and the lowest expression of Kindlin-2 were transfected with miR-200b inhibitor. As shown in Figure 2E , transfection of miR-200b mimic reduced Kindlin-2 expression in all three ESCC cell lines tested, and inhibition of endogenous miR-200b in KYSE150 cells increased Kindlin-2 expression. Lastly, we found a significant inverse correlation between Kindlin-2 protein expression (by IHC) and miR-200b levels (by qRT-PCR) in ESCC samples ( Figure 2F , P = 0.033).
miR-200b and Kindlin-2 regulate invasiveness and migratory function in ESCC
Transfection of miR-200b mimic into three ESCC cell lines (EC9706, EC109 and KYSE510, Figure 3A ), all of which had a low level of miR-200b expression, induced a significant decrease in their cell migration and invasiveness ( Figure 3B and C) . Accordingly, when we inhibited miR-200b using an inhibitor in KYSE150 ( Figure 3A) , an ESCC cell line that expressed miR-200b at the highest level among all ESCC cell lines examined, we found a significant increase in cell migration and invasiveness ( Figure 3B and C). To determine whether Kindlin-2 is a mediator of the biological function of miR200b, two representative cell lines with low miR-200b expression and high Kindlin-2 expression (i.e. EC109 and KYSE510) were used as cell models in our subsequent biological analyses. As shown in Figure 3D and E, siRNA knockdown of Kindlin-2 reduced ESCC cell invasiveness in both EC109 and KYSE510 cells. Furthermore, enforced expression of Kindlin-2 in both EC109 and KYSE510 cells largely restored the invasiveness that was suppressed by miR-200b ( Figure 3F and G).
Both miR-200b and Kindlin-2 regulate actin cytoskeleton and focal adhesion formation in ESCC cells
Previous studies have shown that Kindlin-2 regulates cell-extracellular matrix interaction, cytoskeletal structure, focal adhesion (FA) formation and cell spreading (31) (32) (33) . Based on these observations, we hypothesized that miR-200b may regulate these biological functions via its downregulation of Kindlin-2. This hypothesis was supported by multiple experimental observations. First, after transfection of miR-200b mimic into two ESCC cell lines that express a low level of miR-200b (i.e. EC109 and KYSE510), cell spreading and protrusion formation, two key features dictated by actin cytoskeleton (34) (35) (36) , were substantially inhibited ( Figure 4A ). Second, confocal microscopy analysis showed that enforced expression of miR200b mimic markedly suppressed actin cytoskeleton reorganization, as evidenced by decreased formation of stress fibers and filopodia protrusions in EC109 cells, and diminished podosomes in KYSE510 cells ( Figure 4B and C) . Third, miR-200b mimic repressed the formation of large mature FAs in both cell lines, as revealed by confocal microscopy ( Figure 4B and C) . Finally, quantitative analysis showed that the cell spreading areas were dramatically reduced by miR-200b mimic transfection in both cell lines ( Figure 4D ). As shown in Figure 5A -C, siRNA knockdown of Kindlin-2 in EC109 and KYSE510 largely mimicked the biological effects of transfection of miR-200b mimic, i.e. reduced cell spreading area, decreased stress fibers and FA formation.
Both miR-200b and Kindlin-2 regulate the activity of the Rho-family GTPases
Since members of the Rho-family GTPases have been demonstrated as master regulators of actin cytoskeleton reorganization (37), we speculated that miR-200b might have influenced the cytoskeletal structure by regulating Rho-family GTPases. In support of this concept, transfection with miR-200b mimic significantly repressed the expression levels of GTP-bound Cdc42 and RhoA in both EC109 and KYSE510 cells, suggesting a decreased activity of these Rho-family GTPases ( Figure 6A) . However, the active form of another member of Rho-family GTPases, Rac1, was undetectable in both EC109 and KYSE510 cells (Supplementary Figure 2 , available at Carcinogenesis Online). As shown in Figure 6B , Kindlin-2 knockdown produced similar biological effects as miR-200b mimic transfection in both EC109 and KYSE510 cells. 
Both miR-200b and Kindlin-2 regulate the expression of phospho-FAK (Y397)
Since FA kinase (FAK) has been shown to play a crucial role in the regulation of the formation and turnover of FAs (38, 39) as well as cell spreading (40,41), we examined the biological impact of miR-200b on FAK phosphorylation. As shown in Figure 6C , transfection of miR200b mimic inhibited the phosphorylation of FAK on tyrosine 397 in both EC109 and KYSE510 cells. To determine whether Kindlin-2 plays a role in mediating the biological effects of miR-200b in the modulation of FAK activation, we inhibited Kindlin-2 expression using siRNA. As shown in Figure 6D , knockdown of Kindlin-2 by siRNA also decreased the expression of pFAK(Y397). In contrast, enforced expression of Kindlin-2 markedly restored pFAK(Y397) expression that was suppressed by miR-200b mimic transfection ( Figure 6E ).
Collectively, these findings suggest that Kindlin-2 is an important mediator of the biological functions of miR-200b in ESCC cells.
Discussion
During the past few years, mounting evidence has demonstrated that loss of the miR-200 family promotes tumor initiation by modulating the stemness of cancer stem cells (42) (43) (44) , and enhances tumor malignant progression by regulating epithelial-to-mesenchymal transition and modulating the tumor microenvironment that favors metastasis (10) (11) (12) (13) (14) 45) . However, our understanding about the clinical significance and the biological role of the miR-200 family in ESCC is rather limited. In keeping with the previous concepts, we found that low expression of the members of the miR-200b-200a-429 cluster 
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The impact of miR-200b mimic or anti-200b transfection on cell migration and invasiveness was determined using transwell migration/invasion assays (**P < 0.01, ***P < 0.001, Student's t-test). Representative images of migrated/invaded cells taken under ×200 magnification are shown; average migratory/invasive cells per field were calculated. Data shown are representatives of at least two to three independent experiments. (D) siRNA-mediated knockdown of Kindlin-2 was examined by western blot. Actin was used as an internal control. (E) The impact of Kindlin-2 knockdown on ESCC cell invasiveness was determined using transwell invasion assay as described above (**P < 0.01, ***P < 0.001, Student's t-test). Data shown are representatives of three independent experiments. (F) Forty-eight hours after the transfection of the indicated reagents, Kindlin-2 expression was examined by western blot, and actin was used as an internal control. Western blot bands were quantified using ImageJ software (National Institutes of Health), and the ratios of Kindlin-2/actin were calculated. Vector: pcDNA3.1, Kind2: pcDNA3.1-Kindlin-2. The results shown are representatives of three repeated experiments. (G) Enforced expression of Kindlin-2 largely restored cell invasiveness that was suppressed by miR-200b (*P < 0.05, ***P < 0.001, Student's t-test). Data shown are representatives of three independent experiments. significantly correlate with short patient survival and aggressive phenotypes, the first study that confirms the clinical significance of the miR-200b cluster in ESCC.
Although we have presented compelling evidence that the miR200b cluster is decreased in ESCC and has associated features suggesting tumor suppressor functions, it has been reported that miR200c is overexpressed in ESCC, and high expression of miR-200c confers chemoresistance in ESCC cells (16) . Correlating with these, the expression of the miR-200c and the miR-200b cluster is oppositely altered in ESCC, probably due to the fact that chr1p36 containing the miR-200b cluster is often deleted in ESCC (46) , whereas chr12p13 containing the miR-200c-141 cluster is frequently amplified in ESCC (46, 47) .
Kindlin-2 is a FERM domain containing protein, which has been shown to modulate cell shape by linking the cytoskeleton with the cell-extracellular matrix adhesions (31) (32) (33) . Importantly, Kindlin-2 belongs to Kindlin protein family, which is one of the only two known families of proteins that mediate the inside-out activation of integrin signaling pathways (48) . Currently, the importance of Kindlin-2 in tumor malignant progression has been recognized; Kindlin-2 was 
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shown to highly expressed in the invasive front of tumors and its overexpression promotes cell migration/invasion (23, 24) . However, the expression and the biological significance of Kindlin-2 are not clear in ESCC. In this study, we are the first to identify that Kindlin-2 expression is modulated by miR-200b in ESCC cells, and our data suggest that Kindlin-2 is an important mediator of the biological functions of miR-200b in ESCC. Knockdown of Kindlin-2 phenocopied the suppressor functions of miR-200b in ESCC cell migration/invasiveness, whereas enforced expression of Kindlin-2 reversed the phenotypic effects of miR-200b. A latest report has shown that Kindlin-2 promotes breast cancer invasion by repressing the expression of miR-200b through an epigenetic mechanism (49), suggesting that Kindlin-2 and miR-200 may form a reciprocal feedback loop to regulate tumor progression. Further studies are required to validate this mechanism in ESCC.
We also showed that Kindlin-2 mediated the biological effects of miR-200b on the modulation of cytoskeleton assembly and FA formation, two key processes that regulate cell migratory/invasive properties (35) (36) (37) (38) (39) . Specifically, the dynamic assembly of cytoskeleton regulates cell invasiveness/migration by governing the formation of various migratory organelles, such as stress fibers, lamellipodia, filopodia, invadopodia and podosomes (50) . The formation and turnover of FAs, cell-substratum contact sites that link integrins to the actin cytoskeleton, not only transmit extracellular signals into cells but also facilitate cells to migrate (38, 39) . We found that both enforced expression of miR-200b and Kindlin-2 knockdown suppressed the formation of migratory organelles like stress fibers and filopodia/ podosomes, and inhibited FA formation. Our data also revealed that the miR-200b-Kindlin-2 axis exerts its biological functions via modulating the activity of Rho-family GTPases and FAK, which are well-recognized key regulators of actin cytoskeleton structure and FA formation and turnover, respectively (37) (38) (39) . Thus, our findings suggest that by targeting Kindlin-2, miR-200b is likely to regulate ESCC cell migration and invasion via modulating the cytoskeletal and adhesive machinery. Notably, this mechanism may correlate with our clinical observations that the loss of miR-200b in ESCC tumors is associated with lymph node metastasis, advanced clinical stage and short survival.
Notably, Kindlin-2 knockdown did not perfectly mimic the effects of miR-200b on cell morphology or the assembly of the cytoskeletal machinery (Figures 4 and 5 To conclude, our data reveal a novel mechanism that miR-200b suppresses ESCC aggressiveness and modulates the cytoskeletal and adhesive machinery via targeting Kindlin-2. Our findings also suggest In parallel with the experiments described in A. Cell spreading area was measured with the software ImageJ after adhesion for 1 or 12 h on fibronectin-coated slides, cells from at least three different fields were analyzed (*P < 0.05, **P < 0.01, Student's t-test). (C) In parallel with the experiments described in A, after adhesion for 12 h on fibronectin-coated slides, the average FA number was compared between siNC-and siKind2-transfected cells, cells from at least three different fields were analyzed (*P < 0.05, ***P < 0.001, Student's t-test).
that miR-200b and its targets may serve as promising prognostic markers for ESCC and therapeutic targets for ESCC invasion intervention. Supplementary Figures 1 and 2 and Tables 1-5 
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